Search - tctmd.com

Displaying 1 - 4 of 4

Sort: Relevancy | Date

COVID-19 Drug Candidates May Raise Arrhythmia Risk

News Daily News

COVID-19 Drug Candidates May Raise Arrhythmia Risk

April 03, 2020

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

News Daily News

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

May 04, 2018

News Daily News

Were Problems With the Point-of-Care Device Used in ROCKET AF Kept From the FDA? BMJ Says Yes

September 28, 2016

News Daily News

ROCKET AF Investigators Respond to New Questions About Point-of-Care Warfarin Monitoring Device

July 08, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.